Sanofi
SNY
SNY
546 hedge funds and large institutions have $8.2B invested in Sanofi in 2020 Q1 according to their latest regulatory filings, with 80 funds opening new positions, 185 increasing their positions, 180 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
3% more repeat investments, than reductions
Existing positions increased: 185 | Existing positions reduced: 180
0.62% more ownership
Funds ownership: 14.31% → 14.93% (+0.62%)
9% less capital invested
Capital invested by funds: $9B → $8.2B (-$807M)
Holders
546
Holding in Top 10
11
Calls
$86.7M
Puts
$11.9M
Top Buyers
| 1 | +$323M | |
| 2 | +$203M | |
| 3 | +$129M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$82.1M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$52.2M |
Top Sellers
| 1 | -$472M | |
| 2 | -$20.6M | |
| 3 | -$19.6M | |
| 4 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$17.3M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$15.5M |